Global University Venturing

Immunooncology spinout Neoleukin Therapeutics is working on a safer, synthetic replica of a T-cell-boosting protein called interleukin-2.

Founded out of TUM, transmission gear manufacturer ZG-Zahnräder und Getriebe has been bought by Mahle to bolster its integrated drive system capacity.

ETH Zurich spinouts lifted their total funding haul to $173.3m from $123.1m in 2017.

PetaGene hopes its data compression technology will aid the genomic sequencing industry.

NUI Galway-linked businesses to have secured backing last year include kidney reflux test spinout Kite Medical and medical implant developer Loci Orthopaedics.

The series A funding will help UMass-founded genetic disease therapy developer Apic Bio progress targeted drugs for ALS and Alpha-1 antitrypsin deficiency.

Half a year after raising $500m in a TUS Holdings-backed series B round, the electric car developer is seeking another $500m before it floats.

Biontech, a spinout of Johannes Gutenberg University Mainz, has received $91.5m in funding as part of the extension of a deal to develop a cancer immunotherapy candidate with Sanofi.

Cambridge big data analytics spinout GeoSpock has now raised $24.5m from investors including Cambridge Innovation Capital and Parkwalk Advisors.

University of Chicago’s Polsky Center for Entrepreneurship has formed microbiome-focused Avnovum Therapeutics, BiomeSense, Covira and Oxalo Therapeutics over the past year.

Spun out of Tübingen, Justus Liebig University Gießen and Münster, Atriva Therapeutics has raised an initial $1.4m to progress next-generation antiviral drugs for conditions including influenza.